Carient Heart & Vascular - Manassas

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• High blood pressure4 trials
• Obesity4 trials
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company4 trials

Running trials

• Recruiting

  A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  NCT07783802· Phase 2· Eli Lilly and Company· Source

  Contact: Hamid Taheri (principal investigator)

• Active, not recruiting

  A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

  NCT06948435· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

  NCT06952530· Phase 3· Eli Lilly and Company· Source

• Active, not recruiting

  A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

  NCT06948422· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting